Tag: Ridgeback Biotherapeutics
Merck and Ridgeback Bio collaborate to develop novel antiviral candidate, EIDD-2801
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have...